Regeneron Pharmaceuticals (REGN) Interest Coverage Ratio Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 79.36% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 29.25% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -16.86% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.78% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 40.09% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.78% |
| Dec 31, 2025 | 3.05% |
| Sep 30, 2025 | -12.71% |
| Jun 30, 2025 | 52.39% |
| Mar 31, 2025 | -9.76% |
| Dec 31, 2024 | -20.43% |
| Sep 30, 2024 | -13.06% |
| Jun 30, 2024 | -32.25% |
| Mar 31, 2024 | -15.08% |
| Dec 31, 2023 | -12.31% |
| Sep 30, 2023 | 15.95% |
| Jun 30, 2023 | -7.37% |
| Mar 31, 2023 | -22.90% |
| Dec 31, 2022 | -13.22% |
| Sep 30, 2022 | -5.47% |
| Jun 30, 2022 | 29.02% |
| Mar 31, 2022 | 14.07% |
| Dec 31, 2021 | 24.49% |
| Sep 30, 2021 | 15.37% |
| Jun 30, 2021 | 37.11% |
| Mar 31, 2021 | -4.91% |
| Dec 31, 2020 | -4.16% |
| Sep 30, 2020 | -23.82% |
| Jun 30, 2020 | -12.75% |
| Mar 31, 2020 | 25.98% |
| Dec 31, 2018 | 14.87% |
| Sep 30, 2018 | -28.19% |
| Jun 30, 2018 | -10.43% |
| Mar 31, 2018 | 24.46% |
| Dec 31, 2017 | 31.98% |
| Sep 30, 2017 | 64.32% |
| Jun 30, 2017 | 65.66% |
| Mar 31, 2017 | 51.53% |
| Dec 31, 2015 | 71.60% |
| Sep 30, 2015 | 134.56% |
| Jun 30, 2015 | 152.61% |
| Mar 31, 2015 | 184.82% |
| Dec 31, 2014 | 116.25% |
| Sep 30, 2014 | 50.64% |
| Jun 30, 2014 | 51.88% |
| Mar 31, 2014 | 51.79% |
| Dec 31, 2013 | 73.45% |
| Sep 30, 2013 | 50.44% |
| Jun 30, 2013 | 49.98% |
| Mar 31, 2013 | 43.36% |
| Dec 31, 2012 | 36.88% |
| Sep 30, 2012 | 115.30% |